AN2 Therapeutics (ANTX) Interest & Investment Income (2021 - 2026)
AN2 Therapeutics (ANTX) reported Interest & Investment Income of $523000.0 for Q1 2026, down 41.1% year-over-year from $888000.0 in Q1 2025, and down 13.55% quarter-over-quarter from $605000.0 in Q4 2025.
AN2 Therapeutics (ANTX) Interest & Investment Income (2021 - 2026) Analysis & Trends
AN2 Therapeutics (ANTX) has 5 years of Interest & Investment Income data on file, last reported at $523000.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $523000.0, down 41.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (down 45.06% YoY), and the FY2025 annual result was $2.9 million, down 46.32% from the prior year.
- Interest & Investment Income retreated to $523000.0 in Q1 2026 per ANTX's latest filing, from $605000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.7 million in Q1 2024 and troughed at $27000.0 in Q1 2022.
- A 4-year average of $790307.7 and a median of $687000.0 in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income soared 2233.33% in 2022, then tumbled 47.82% in 2025.
- A 4-year view of Interest & Investment Income shows it stood at $630000.0 in 2022, then soared by 70.79% to $1.1 million in 2024, then slumped by 43.77% to $605000.0 in 2025, then slipped by 13.55% to $523000.0 in 2026.
- Business Quant data shows ANTX's Interest & Investment Income at $523000.0 in Q1 2026, $605000.0 in Q4 2025, and $687000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | AN2 Therapeutics | 161.95 Mn | 161.95 Mn | - | 523,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 523,000.00 |
| Dec 31, 2025 | 605,000.00 |
| Sep 30, 2025 | 687,000.00 |
| Jun 30, 2025 | 754,000.00 |
| Mar 31, 2025 | 888,000.00 |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2022 | 630,000.00 |
| Sep 30, 2022 | 466,000.00 |
| Jun 30, 2022 | 228,000.00 |
| Mar 31, 2022 | 27,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 25,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Mar 31, 2021 | 2,000.00 |